Walgreens Boots Alliance Stock (NASDAQ: WBA)

Walgreens Boots Alliance (NASDAQ:WBA) Stock

Walgreens Boots Alliance

Walgreens Boots Alliance is one of the largest retail pharmacy chains in the US, with over 8,000 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the US. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.

Screenshot 2025-02-21 at 6.41.09 PM

Emerging Markets

Movers & Shakers

AMOD

From Innovating To Protecting Its Shareholders: Alpha Modus&#39;s Strategy To Transform The Retail Market

Walgreens Defends Its Actions

Large Cap

News

Health Care

Rumors

Movers

Trading Ideas

General

Walgreens is in talks with Sycamore Partners for a potential buyout.

Why Is Walgreens Boots Alliance Stock Trading Higher On Tuesday?

SPOK


When it comes to dividend performers, healthcare usually takes a backseat to options like REITs and energy stocks. However, the sector’s resilience, driven by aging populations and consistent demand for

High-Yield Healthcare: 3 Stocks With Strong Dividends

Walgreens Boots Alliance, Inc. - Common Stock

Walgreens Boots Alliance Inc

WisdomTree Trust WisdomTree Battery Value Chain and Innovation Fund

As per a media report in December, Walgreens Boots Alliance Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) suggested the company is in talks to be acquired by Sycamore Partners.
Walgreens's market value has shrunk from over $100 billion a decade ago to around $8.4 billion, as per data from <a target="_blank" href="https://www.benzinga.com/pro/feature/newsfeed" rel="noreferrer noopener">Benzinga Pro</a>.
Earlier on Tuesday, citing CNBC, the Bloomberg <a target="_blank" href="https://www.bloomberg.com/news/articles/2025-02-18/walgreens-gains-after-cnbc-says-sycamore-takeout-is-alive" rel="noreferrer noopener">report</a> noted that the take-private deal with the private equity firm&nbsp;is still possible.
Walgreens Boots Alliance' deal appeared "mostly dead a couple of weeks ago," CNBC's&nbsp;David Faber&nbsp;said Tuesday. He said he was now upgrading the deal to "alive."
Also Read: <a target="_blank" href="https://www.benzinga.com/25/02/43557922/debt-strategy-in-motion-walgreens-early-cencora-share-settlement-unlocks-300-million" rel="noreferrer noopener">Walgreens Cashes In: Slashes Cencora Stake Again In Debt-Fighting Move</a>
The Wall Street report in December, citing people familiar with the matter, said Sycamore would likely sell certain parts of the business or bring in partners. The people also said the deal could be <a target="_blank" href="https://www.benzinga.com/24/12/42421855/walgreens-stock-jumps-on-report-of-potential-private-equity-sale-what-you-need-to-know" rel="noreferrer noopener">completed in early 2025</a>.
Recently, the drugstore chain announced its board is suspending its cash dividend as management continues to evaluate its capital allocation policy as part of a longer-<a target="_blank" href="https://www.benzinga.com/trading-ideas/dividends/25/01/43357768/walgreens-boots-alliance-shares-slide-as-board-suspends-dividend" rel="noreferrer noopener">term turnaround strategy</a>.
In January, Walgreens reported first-quarter sales of $39.46 billion, up 7.5% year over year (+6.9% on constant currency), beating the&nbsp;consensus of $37.28 billion, reflecting sales growth across all segments.
Walgreens maintained fiscal 2025 adjusted EPS&nbsp;guidance of $1.40 – $1.80 versus the <a target="_blank" href="https://www.benzinga.com/general/health-care/25/01/42912519/walgreens-boots-alliance-stock-jumps-on-better-than-expected-q1-earnings-sticks-to-annual-profit-forecast" rel="noreferrer noopener">consensus of $1.52</a>.
The company&nbsp;expects&nbsp;growth in U.S. Healthcare and International to be offset by pressure in U.S. Retail Pharmacy, largely driven by weaker retail front-end performance.
Earlier this year,&nbsp;the U.S. Department of Justice filed a civil complaint against&nbsp;Walgreens and its subsidiaries, alleging widespread violations of the Controlled Substances Act (CSA) and <a target="_blank" href="https://www.benzinga.com/25/01/43104245/justice-department-accuses-walgreens-of-violating-drug-laws-in-opioid-epidemic-ignored-red-flags-in-opioid-crisis" rel="noreferrer noopener">False Claims Act (FCA)</a>.
The&nbsp;<a target="_blank" href="https://www.justice.gov/opa/pr/justice-department-files-nationwide-lawsuit-alleging-walgreens-knowingly-filled-millions" rel="noreferrer noopener">complaint</a> claims that Walgreens dispensed millions of unlawful prescriptions, including opioids, and sought reimbursements from federal health care programs for prescriptions that were improperly filled.
Price Action: WBA stock is up 12.1% at $10.88 at last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/02/43778265/baidu-q4-earnings-ai-cloud-grows-margin-slides-expects-ai-investments-to-bear-fruit-in-2025" target="_blank" rel="noreferrer noopener">Baidu Q4 Earnings: AI Cloud Grows, Margin Slides, Expects AI Investments To Bear Fruit In 2025</a></li>
</ul>
Image via Shutterstock

WIIM

Walgreens shares are trading higher after reports suggesting the Sycamore takeout offer is still "alive."

<a href="https://www.bloomberg.com/news/articles/2025-02-18/walgreens-gains-after-cnbc-says-sycamore-takeout-is-alive" title="https://www.bloomberg.com/news/articles/2025-02-18/walgreens-gains-after-cnbc-says-sycamore-takeout-is-alive">https://www.bloomberg.com/news/articles/2025-02-18/walgreens-gains-after-cnbc-says-sycamore-takeout-is-alive</a>

"Walgreens Gains After CNBC Says Sycamore Takeout Is 'Alive'" - Bloomberg News

Legal

Walgreen Co Must Pay More Than $987M To Satisfy An Arbitration Award Won By Telemedicine Provider PWNHealth, A Federal Judge In Delaware Ruled On Monday.

On Thursday, Walgreens Boots Alliance, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) reached an agreement for the early settlement of certain prepaid variable share forward transactions related to shares of Cencora, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COR#NYSE">COR</a>).
As part of the early settlement, Walgreens Boots will transfer approximately 6.1 million Cencora shares to the financial institutions and make a net cash payment of about $20 million.
Alongside this, the company executed a sale of the remaining 1.3 million shares of Cencora pledged under the early settled contracts. The company receives approximately&nbsp;$300 million&nbsp;from the early settlement and the concurrent sale of shares.
Following this settlement, WBA retains 12.6 million Cencora shares under remaining prepaid contracts, set to mature primarily in March, June, and September 2025, with the potential for additional cash proceeds.
The proceeds will primarily be used for debt reduction and general corporate purposes.&nbsp;&nbsp;The transactions were scheduled to mature in March and June 2026.
By settling early and executing a concurrent share sale, WBA is realizing the embedded cash value of the prepaid variable share forwards. With this settlement, Walgreens has lowered its stake in Cencora from 10% to 6%.
Notably, Walgreens has been cutting its stake in Concera for the last few years, decreasing the stake from 12% to 10% for around <a target="_blank" href="https://www.benzinga.com/pressreleases/24/08/b40119033/walgreens-boots-alliance-sells-shares-of-cencora-for-approximately-1-1-billion-of-proceeds" rel="noreferrer noopener">$1.1 billion in August 2024</a>.
Also, in May 2024,&nbsp;Walgreens reduced ownership of Cencora shares from 13% to <a target="_blank" href="https://www.benzinga.com/pressreleases/24/05/b38975615/walgreens-boots-alliance-sells-shares-of-cencora-for-400-million-of-proceeds" rel="noreferrer noopener">12% for approximately $400 million</a>.
These transactions, along with other recent measures such as the dividend suspension, further strengthen WBA&#8217;s ability to address its upcoming debt maturities in fiscal 2026.
Last month, the company announced it is halting its quarterly dividend while the management team reviews and adjusts its capital allocation strategy to match the company&#8217;s <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/01/43397182/whats-going-on-with-walgreens-shares-friday-2" rel="noreferrer noopener">broader long-term recovery efforts</a>.
Investors can gain exposure to the stock via Invesco High Yield Equity Dividend Achievers ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEY#NASDAQ">PEY</a>) and Invesco S&amp;P 500 Equal Weight Consumer Staples ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RSPS#NYSE">RSPS</a>).
Price Action: WBA shares are up 0.40% at $10.09 premarket at the last check Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/01/43390001/feds-favorite-inflation-gauge-rises-as-predicted-consumer-spending-jumps-at-fastest-pace-in-9-months" target="_blank" rel="noreferrer noopener">Fed&#8217;s Favorite Inflation Gauge Rises As Predicted, Consumer Spending Jumps At Fastest Pace In 9 Months</a></li>
</ul>
Image via Shutterstock.

Equities

Mid Cap

RSPS

Walgreens Cashes In: Slashes Cencora Stake Again In Debt-Fighting Move

Transaction Highlights
<ul>
<li>Walgreens Boots Alliance announces early settlement of certain prepaid variable share forward transactions with respect to shares of Cencora for delivery of an aggregate 6.1 million shares</li>
<li>Concurrent with the early settlement, the Company executed a sale of the remaining 1.3 million shares of Cencora pledged under the early settled contracts. The Company receives approximately $300 million from the early settlement and the concurrent sale of shares</li>
<li>Following today's early settlement, the Company owns approximately 12.6 million shares of Cencora pledged under the remaining prepaid variable share forward contracts, which have the potential to provide additional cash proceeds at maturity. These remaining prepaid variable share forward contracts are mainly scheduled to mature during March, June and September of calendar year 2025.</li>
<li>Use of proceeds will primarily be for debt paydown, as the Company proactively seeks to address its debt maturities in fiscal year 2026, and for general corporate purposes</li>
</ul>

Reported Earlier, Walgreens Boots Alliance Secures $300M Through Early Settlement Of Prepaid Variable Share Forward Contracts On Cencora

Alpha Modus Files Patent Infringement Lawsuit Against Walgreens, Claiming Walgreens Infringed On Co.'s AI-Driven Retail Technology

<a href="https://www.bloomberg.com/news/articles/2025-01-31/walgreens-suspends-dividend-while-suitor-sycamore-seeks-deal-financing" title="https://www.bloomberg.com/news/articles/2025-01-31/walgreens-suspends-dividend-while-suitor-sycamore-seeks-deal-financing">https://www.bloomberg.com/news/articles/2025-01-31/walgreens-suspends-dividend-while-suitor-sycamore-seeks-deal-financing</a>

'As Walgreens Looks to Save Cash, Suitor Sycamore Seeks Funding' - Bloomberg News

In the preceding three months, 6 analysts have released ratings for Walgreens Boots Alliance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>), presenting a wide array of perspectives from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">5</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $11.08, a high estimate of $13.00, and a low estimate of $8.50. This current average has increased by 8.1% from the previous average price target of $10.25. 
<img src="https://www.benzinga.com/files/images/story/2025/1738346434_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
A comprehensive examination of how financial experts perceive Walgreens Boots Alliance is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>David Macdonald</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$12.00</td>
<td>$13.00</td>
</tr>
<tr>
<td>David Macdonald</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Hold</td>
<td>$13.00</td>
<td>$10.00</td>
</tr>
<tr>
<td>Ben Hendrix</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$12.00</td>
<td>$9.00</td>
</tr>
<tr>
<td>Elizabeth Anderson</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>In-Line</td>
<td>$12.00</td>
<td>$9.00</td>
</tr>
<tr>
<td>Allen Lutz</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Underperform</td>
<td>$8.50</td>
<td>$7.50</td>
</tr>
<tr>
<td>Ben Hendrix</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$9.00</td>
<td>$13.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Walgreens Boots Alliance. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Walgreens Boots Alliance compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Walgreens Boots Alliance's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Walgreens Boots Alliance's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/WBA/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Walgreens Boots Alliance analyst ratings.</a>
<h2>Get to Know Walgreens Boots Alliance Better</h2>
Walgreens Boots Alliance is one of the largest retail pharmacy chains in the US, with over 8,000 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the US. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.
<h3>Financial Insights: Walgreens Boots Alliance</h3>
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
Positive Revenue Trend: Examining Walgreens Boots Alliance's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 7.5% as of 30 November, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Consumer Staples sector.
Net Margin: Walgreens Boots Alliance's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of -0.67%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Walgreens Boots Alliance's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -2.6% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Walgreens Boots Alliance's ROA stands out, surpassing industry averages. With an impressive ROA of -0.33%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 3.09, caution is advised due to increased financial risk.
<h2>Analyst Ratings: Simplified</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

Breaking Down Walgreens Boots Alliance: 6 Analysts Share Their Views

U.S. stocks traded mostly higher midway through trading, with the Nasdaq Composite gaining more than 1% on Friday.
The Dow traded down 0.04% to 44,865.23 while the NASDAQ climbed 1.15% to 19,908.53. The S&amp;P 500 also rose, gaining, 0.57% to 6,105.94.
Check This Out: <a href="https://www.benzinga.com/25/01/43388778/jim-cramer-autozone-is-a-great-stock-recommends-buying-this-energy-stock">Jim Cramer: AutoZone Is A &#8216;Great&#8217; Stock, Recommends Buying This Energy Stock</a>
Leading and Lagging Sectors Communication services shares surged by 1.6% on Friday.
In trading on Friday, energy shares fell by 2.3%.
Top Headline
Exxon Mobil Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>) reported better-than-expected fourth-quarter earnings.
Total revenues and other income stood at $83.4 billion, missing the consensus of $86.6 billion.
Net production in the fourth quarter was 4.6 million oil-equivalent barrels per day, an increase of 20,000 oil-equivalent barrels per day from the prior quarter.
Adjusted net profit came in at $7.39 billion, down from $8.61 billion in the prior quarter. Adjusted EPS stood at $1.67, beating the consensus of $1.56.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Viavi Solutions Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIAV#NASDAQ">VIAV</a>) shares shot up 27% to $12.72 after the company reported better-than-expected second-quarter financial results.</li>
<li>Shares of Signing Day Sports, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SGN#NYSE">SGN</a>)got a boost, surging 65% to $4.2199 after the company announced it retains rights as the National Recruiting Partner to the U.S. Army Bowl through 2026 in new deal.</li>
<li>NLS Pharmaceutics AG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NLSP#NASDAQ">NLSP</a>) shares were also up, gaining 37% to $2.7210 after announcing its merger with Kadimastem has been approved by shareholders.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Enveric Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENVB#NASDAQ">ENVB</a>) shares dropped 46% to $2.1110 after the company announced a $5 million public offering of 1.67 million units of common stock.</li>
<li>Shares of NewGenIvf Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIVF#NASDAQ">NIVF</a>) were down 38% to $0.1593 after the company announced a 1-for-20 reverse stock split.</li>
<li>Walgreens Boots Alliance, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) was down, falling 16% to $9.61 after the company announced it suspended its quarterly dividend.</li>
</ul>
Commodities In commodity news, oil traded up 0.1% to $72.83 while gold traded up 0.2% at $2,850.90.
Silver traded up 0.5% to $32.665 on Friday, while copper fell 0.5% to $4.2845.
Euro zone
European shares were mixed today. The eurozone's STOXX 600 rose 0.16%, Germany's DAX 40 fell 0.08% and France's CAC 40 climbed 0.03%. Spain's IBEX 35 Index fell 0.24%, while London's FTSE 100 rose 0.24%.
Asia Pacific Markets
Asian markets closed higher on Friday, with Japan's Nikkei 225 gaining 0.15% and India's BSE Sensex gaining 0.97%.
Economics
<ul>
<li>U.S. personal income increased 0.4% month-over-month in December compared to a 0.3% gain in November.</li>
<li>Personal spending climbed by 0.7% month-over-month to an annualized rate of $20.387 trillion in December.</li>
<li>The core PCE price index in the US increased by 0.2% from the previous month for December.</li>
<li>The Chicago PMI climbed to 39.5 in January from 36.9 in the previous month.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43390127/wall-streets-most-accurate-analysts-give-their-take-on-3-energy-stocks-delivering-high-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Energy Stocks Delivering High-Dividend Yields</a></li>
</ul>

Earnings

Eurozone

Commodities

Intraday Update

Markets

ENVB

NIVF

NLSP

VIAV

Dow Edges Lower; Exxon Mobil Earnings Top Views

Walgreens Boots Alliance, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) shares are moving lower on Friday after the company announced on Thursday that it suspended <a href="https://www.benzinga.com//node/43357768">its quarterly dividend</a>.
What To Know: The company announced it is halting its quarterly dividend while the management team reviews and adjusts its capital allocation strategy to match the company&#8217;s broader long-term recovery efforts.
The goal is to enhance Walgreen&#8217;s financial position by prioritizing debt reduction and improving free cash flow. Furthermore, the company&#8217;s cash needs over the next several years, including those related to litigation and debt refinancing, were key factors in the decision to suspend the dividend.
Walgreens said in the press release that, &#8220;WBA leadership remains focused on successfully executing against its strategic priorities and maintaining financial discipline, which it believes will deliver sustained value creation over the long term.&#8221;
How To Buy Walgreens Stock
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Walgreens Boots Alliance's case, it is in the Consumer Staples sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
See Also: <a href="https://www.benzinga.com/25/01/43391377/these-analysts-lower-their-forecasts-on-dow-after-downbeat-earnings">These Analysts Lower Their Forecasts On Dow After Downbeat Earnings</a>
WBA Price Action: At the time of writing, Walgreens stock is trading 12.4% lower at $10.04, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro.</a>
Image: via Walgreens Boots Alliance.

What's Going On With Walgreens Shares Friday?

Truist Securities analyst David Macdonald maintains Walgreens Boots Alliance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) with a Hold and lowers the price target from $13 to $12.

Price Target

Truist Securities Maintains Hold on Walgreens Boots Alliance, Lowers Price Target to $12

Editor&#8217;s note: This story has been updated with additional details. 
The Federal Reserve&#8217;s preferred inflation measure surged as predicted last month, quelling headwinds for the central bank&#8217;s goal of gradually reaching the 2% target, while a strong surge in personal spending continued to reiterate the <a href="https://www.benzinga.com/news/econ-s">health of U.S. consumers.</a>
The Personal Consumption Expenditures price index rose 2.6% in December 2024 on a year-over-year basis, according to data released Friday. This means an acceleration from the previous 2.4% but in line with economic forecasts of 2.6%, as tracked by TradingEconomics estimates.
It&#8217;s also the third consecutive increase in annual PCE inflation, following a low of 2.1% in September last year. On a monthly basis, the PCE price index rose 0.3%, up from 0.1% in the prior month, but in line with expectations.
Core PCE inflation, which excludes volatile energy and food prices, held steady at 2.8% year over year, matching forecasts. On a monthly basis, core PCE rose 0.2%, also aligning with estimates.
In its December macroeconomic projections, the Federal Reserve raised its 2025 inflation outlook, expecting both headline and core PCE inflation to average 2.5% in 2025.
Personal income increased 0.4% month over month in December, accelerating from 0.3% in November, in line with expectations.
&#8220;The increase in personal income in December primarily reflected an increase in compensation, led by private wages and salaries,&#8221; the Bureau of Economic Analysis wrote. 
Personal spending spiked 0.7%, up from the previous 0.6%, beating forecasts of 0.5% and marking the strongest increase since March 2024. 
The highest changes in monthly consumer spending occurred in housing and utilities, up by $29.8 billion, transportation services, up $25.9 billion, and gasoline and other energy goods, up $21.8 billion. 
<h3 class="wp-block-heading">Market Reactions</h3>
The U.S. dollar index, which is tracked by the&nbsp;Invesco DB USD Index Bullish Fund ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UUP#NYSE">UUP</a>), held broadly steady minutes after the release.
Treasury yields inched marginally higher,&nbsp;with the 10-year yield up by 2&nbsp;basis points to 4.54%. 
Futures on major U.S. indices traded mostly in the green in New York premarket trading, with contracts on the S&amp;P 500 up 0.5%, although a tad lower following the PCE release. On Thursday, the SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) closed 0.5% higher.
Sector-wise, the Technology Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>) led gains, up 1%, driven by a 4.2% premarket surge in Apple Inc.
The Consumer Staples&nbsp;Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>) was the laggard, falling 0.5%, weighed down a 14% drop in Walgreens Boots Alliance Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>). 
Gold prices – tracked by the SPDR Gold Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLD#NYSE">GLD</a>) – remained steady at record highs of $2,800 per ounce, up 0.4% for the day. 
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/econ-s/25/01/43348204/gold-hits-record-high-as-central-banks-ease-stance-5-mining-stocks-rally">Gold Hits Record High As Central Banks Ease Stance: 5 Mining Stocks Rally</a></li>
</ul>

Macro Economic Events

Broad U.S. Equity ETFs

Econ #s

Economics

Federal Reserve

ETFs

PowerShares DB US Dollar Index Bullish Fund

Fed's Favorite Inflation Gauge Rises As Predicted, Consumer Spending Jumps At Fastest Pace In 9 Months (UPDATED)

U.S. stock futures were higher this morning, with the Dow futures gaining around 150 points on Friday.
Shares of Walgreens Boots Alliance, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) fell sharply in today's pre-market trading after the company suspended its <a href="https://in.benzinga.com/trading-ideas/dividends/25/01/43357768/walgreens-boots-alliance-shares-slide-as-board-suspends-dividend">quarterly dividend</a>.
After the market close on Thursday, Walgreens announced its board is suspending its cash dividend as management continues to evaluate its capital allocation policy as part of a longer-term turnaround strategy.
Walgreens shares dipped 10.4% to $10.28 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul>
<li>Deckers Outdoor Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DECK#NYSE">DECK</a>) fell 15.1% to $189.32 in pre-market trading after the company reported third-quarter results.</li>
<li>Beazer Homes USA, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BZH#NYSE">BZH</a>) declined 8.6% to $25.33 in pre-market trading following worse-than-expected reported first-quarter financial results.</li>
<li>Olin Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLN#NYSE">OLN</a>) fell 8.4% to $29.44 in pre-market trading following fourth-quarter earnings results.</li>
<li>Boot Barn Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOOT#NYSE">BOOT</a>) shares declined 6.6% to $162.99 in pre-market trading following third-quarter results.</li>
<li>Vestis Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VSTS#NYSE">VSTS</a>) fell 6.2% to $14.86 in pre-market trading following first-quarter results.</li>
<li>PPG Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PPG#NYSE">PPG</a>) fell 3.9% to $118.00 in pre-market trading following downbeat earnings.</li>
<li>Booz Allen Hamilton Holding Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAH#NYSE">BAH</a>) fell 2.3% to $126.01 in pre-market trading following third-quarter results.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43335398/wall-streets-most-accurate-analysts-spotlight-on-3-risk-off-stocks-delivering-high-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Risk Off Stocks Delivering High-Dividend Yields</a></li>
</ul>

Pre-Market Outlook

BOOT

DECK

VSTS

Walgreens, Deckers Outdoor, Beazer Homes And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Walgreens Boots Alliance shares are trading lower after the company announced it suspended its quarterly dividend.

Shares of Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) rose sharply in today's pre-market trading after the company reported <a href="https://in.benzinga.com/news/earnings/25/01/43355688/apple-q1-earnings-revenue-beat-eps-beat-iphone-sales-slip-installed-base-climbs-to-all-time-high-our-best-quarter-ever">better-than-expected first-quarter results.</a>
Apple reported fiscal first-quarter revenue of $124.3 billion, beating analyst estimates of $124.13 billion. The iPhone maker reported first-quarter adjusted earnings of $2.40 per share, beating analyst estimates of $2.36 per share.
Apple shares gained 3.4% to $245.73 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Trident Digital Tech Holdings Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TDTH#NASDAQ">TDTH</a>) gained 104% to $1.94 in pre-market trading after dipping 62% on Thursday.</li>
<li>Nauticus Robotics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KITT#NASDAQ">KITT</a>) rose 63.4% to $2.55 in pre-market trading after announcing a partnership to advance subsea autonomy solutions.</li>
<li>Diginex Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DGNX#NASDAQ">DGNX</a>) gained 40% to $49.01 in pre-market trading after dipping 30% on Thursday.</li>
<li>Orangekloud Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORKT#NASDAQ">ORKT</a>) gained 37.2% to $1.88 in pre-market trading. Maxim Group analyst Allen Klee initiated coverage on Orangekloud Technology with a Buy rating and announced a price target of $5.</li>
<li>Cyclerion Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCN#NASDAQ">CYCN</a>) rose 25.1% to $3.18 in pre-market trading after gaining 7% on Thursday.</li>
<li>Envirotech Vehicles, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVTV#NASDAQ">EVTV</a>) shares jumped 17.7% to $0.4077 in pre-market trading after dipping 48% on Thursday. Envirotech Vehicles recently announced it has received orders for 48 vehicles to New Jersey.</li>
<li>Cipher Mining Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CIFR#NASDAQ">CIFR</a>) gained 20.9% to $5.68 in pre-market trading after the company announced a $50 million investment from Softbank.</li>
<li>Atlassian Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEAM#NASDAQ">TEAM</a>) rose 18.9% to $317.40 in pre-market trading after the company reported better-than-expected second-quarter financial results.</li>
<li>Kimball Electronics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KE#NASDAQ">KE</a>) gained 11% to $20.11 in pre-market trading. Kimball Electronics will report second quarter fiscal year 2025 financial results on Tuesday, Feb. 4, 2025, after the closing bell.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Aviat Networks, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVNW#NASDAQ">AVNW</a>) shares fell 46.5% to $10.00 in pre-market trading. Aviat Networks will release its second quarter fiscal 2025 financial results for the period ended Dec. 27, 2024, on Feb. 4, 2025, after the closing bell.</li>
<li>Enveric Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENVB#NASDAQ">ENVB</a>) dipped 39.7% to $2.35 in pre-market trading after the company priced $5 million public offering of 1.67 million common stock &amp; warrants at $3.00/share.</li>
<li>Stabilis Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNG#NASDAQ">SLNG</a>) shares fell 19.7% to $6.00 in pre-market trading.</li>
<li>Klotho Neurosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLTO#NASDAQ">KLTO</a>) fell 19.1% to $0.3202 in today's pre-market trading.</li>
<li>Benson Hill, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BHIL#NASDAQ">BHIL</a>) shares dipped 18.7% to $3.21 in pre-market trading. Benson Hill shares jumped 119% on Thursday after the company announced results from a controlled broiler feeding trial conducted with Tyson Foods.</li>
<li>American Strategic Investment Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NYC#NYSE">NYC</a>) shares tumbled 17.8% to $8.01 in pre-market trading.</li>
<li>Deckers Outdoor Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DECK#NYSE">DECK</a>) fell 15.1% to $189.32 in pre-market trading after the company reported third-quarter results.</li>
<li>Walgreens Boots Alliance, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) fell 10.4% to $10.28 in pre-market trading after the company suspended its quarterly dividend.</li>
<li>Beazer Homes USA, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BZH#NYSE">BZH</a>) declined 8.6% to $25.33 in pre-market trading following worse-than-expected reported first-quarter financial results.</li>
<li>Olin Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLN#NYSE">OLN</a>) fell 8.4% to $29.44 in pre-market trading following fourth-quarter earnings results.</li>
</ul>
Now Read This:
<ul>
<li><a href="https://www.benzinga.com/25/01/43335398/wall-streets-most-accurate-analysts-spotlight-on-3-risk-off-stocks-delivering-high-dividend-yields"> Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Risk Off Stocks Delivering High-Dividend Yields</a></li>
</ul>

AAPL

AVNW

BHIL

CIFR

CYCN

DGNX

EVTV

KITT

KLTO

ORKT

SLNG

TDTH

TEAM

Why Apple Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

Despite the slower-than-expected economic growth in the US for the final quarter of 2024, the stock market ended in the green on Thursday. The S&amp;P 500 and Nasdaq indices witnessed a rise of 0.5% and 0.4% respectively, as the GDP growth rate <a href="https://www.benzinga.com/economics/macro-economic-events/25/01/43336153/us-economy-grows-below-q4-estimates-as-consumer-spending-hits-7-quarter-high">fell short of the forecasted 2.6% expansion</a>. The tech-heavy Nasdaq ended the day 0.25% higher at 19,681.75.
These are the top stocks that gained the attention of retail traders and investors throughout the day:
Apple Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>)
Apple&#8217;s stock dipped by 0.74%, closing at $237.59. However, the shares were seen trading nearly 3% higher in the after-hours session. The intraday high and low were $240.79 and $237.21, respectively, with a 52-week range of $260.09 to $164.08. The tech giant reported a successful first quarter, with <a href="https://in.benzinga.com/news/earnings/25/01/43355688/apple-q1-earnings-revenue-beat-eps-beat-iphone-sales-slip-installed-base-climbs-to-all-time-high-our-best-quarter-ever">revenue of $124.3 billion</a> and adjusted earnings of $2.40 per share, both surpassing analyst estimates. 
Intel Corp.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>)
Intel&#8217;s shares rose by 1.32%, closing at $20.01. The intraday high and low were $20.10 and $19.43, respectively, with a 52-week range of $46.63 to $18.51. Investors were closely watching the company&#8217;s CEO search and potential segment spin-offs following its fourth-quarter financial report. The company <a href="https://www.benzinga.com/news/earnings/25/01/43354712/intel-stock-climbs-on-better-than-expected-q4-report-details">reported earnings per share</a> of 13 cents which beat the consensus estimate of 12 cents.
Walgreens Boots Alliance Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>)
Walgreens&#8217; stock climbed by 1.87%, closing at $11.46. The intraday high and low were $11.60 and $11.25, respectively, with a 52-week range of $23.77 to $8.08. The company announced the <a href="https://www.benzinga.com/trading-ideas/dividends/25/01/43357768/walgreens-boots-alliance-shares-slide-as-board-suspends-dividend">suspension of its quarterly dividend</a> as part of a longer-term turnaround strategy. 
United Parcel Service Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>)
UPS shares plummeted by 14.11%, closing at $114.9. The intraday high and low were $117.98 and $109.62, respectively, with a 52-week range of $158.95 to $109.62. The company reported a YoY <a href="https://www.benzinga.com/news/earnings/25/01/43335015/ups-q4-earnings-major-customer-volume-cut-raises-jitters-stock-tanks">consolidated revenue growth</a> of 1.5% in the fourth quarter, missing the consensus. 
Tesla Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)
Tesla&#8217;s stock rose by 2.87%, closing at $400.28. The intraday high and low were $412.50 and $384.41, respectively, with a 52-week range of $488.54 to $138.80. CEO Elon Musk announced that the production of the new Model Y vehicle would result in <a href="https://www.benzinga.com/25/01/43328898/elon-musk-warns-teslas-new-model-y-will-result-in-several-weeks-of-lost-production-for-ev-giant-in-q1">several weeks of lost production</a> in the first quarter.
Image via Shutterstock
Prepare for the day&#8217;s trading <a href="https://editorial.benzinga.com/wp-admin/Premarket%20Movers%20&amp;%20News">with top premarket movers and news</a> by Benzinga.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/01/43373930/ross-gerber-says-robotaxi-is-here-and-it-is-a-waymo-from-google-highlights-teslas-severe-hardware-limitations">Ross Gerber Says Robotaxi Is Here And It Is A Waymo From Google, Highlights Tesla&#8217;s &#8216;Severe Hardware Limitations&#8217;</a></li>
</ul>
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>

INTC

TSLA

Apple, Intel, Walgreens, UPS, And Tesla: Why These 5 Stocks Are On Investors' Radars Today

Walgreens Boots Alliance Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) shares are falling in extended trading Thursday after the company <a href="https://www.benzinga.com/pressreleases/25/01/b43355741/walgreens-boots-alliance-suspends-quarterly-dividend-as-company-continues-disciplined-execution-ag">suspended its quarterly dividend</a>.
What Happened: After the market close on Thursday, Walgreens announced its board is suspending its cash dividend as management continues to evaluate its capital allocation policy as part of a longer-term turnaround strategy.
The suspended dividend is expected to help strengthen the company&#8217;s balance sheet by reducing debt over time and improving free cash flow.
&#8220;The company&#8217;s cash needs over the next several years, including with respect to litigation and debt refinancing, were important considerations as part of the decision to suspend the dividend,&#8221; the company said. 
&#8220;WBA leadership remains focused on successfully executing against its strategic priorities and maintaining financial discipline, which it believes will deliver sustained value creation over the long term.&#8221;
<h1 class="wp-block-heading">How To Buy WBA Stock</h1>
By now you're likely curious about how to participate in the market for Walgreens — be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share. 
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading — either way it allows you to profit off of the share price decline.
WBA Price Action: <a href="http://benzinga.com/quote/wba">Walgreens shares</a> were down 7.77% after-hours, trading at $10.52 at the time of publication Thursday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/01/43355688/apple-q1-earnings-revenue-beat-eps-beat-iphone-sales-slip-installed-base-climbs-to-all-time-high-our-best-quarter-ever">Apple Q1 Earnings: Revenue Beat, EPS Beat, iPhone Sales Slip, Installed Base Climbs To All-Time High — &#8216;Our Best Quarter Ever&#8217;</a></li>
</ul>
Photo: Courtesy of Walgreens Boots Alliance.

Dividends

After-Hours Center

Walgreens Boots Alliance Shares Slide As Board Suspends Dividend

Walgreens Boots Alliance Says Its Cash Needs Over Next Several Years, Including With Respect To Litigation And Debt Refinancing, Were Important Considerations To Suspend Dividend

Walgreens Boots Alliance Suspends Quarterly Dividend

Press Releases

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Walgreens Boots Alliance, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - WBA

INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Walgreens Boots Alliance, Inc. and Certain Officers - WBA

Robbins LLP Reminds Investors of Walgreens Boots Alliance, Inc. (WBA) of the Pending Lead Plaintiff Deadline and Urges Investors to Obtain Counsel

WBA INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Walgreens Boots Alliance, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 31, 2025 in Walgreens Boots Alliance, Inc. Lawsuit - WBA

Grubhub Adds Walgreens to Grow its Convenience Offerings and Give Customers More Choices

Contact The Gross Law Firm by March 31, 2025 Deadline to Join Class Action Against Walgreens Boots Alliance, Inc.(WBA)

March 31, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against WBA

Shareholders of Walgreens Boots Alliance, Inc. Should Contact Levi & Korsinsky Before March 31, 2025 to Discuss Your Rights – WBA

WBA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Walgreens Boots Alliance, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Comments

Walgreens Boots Alliance

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga